DA-1229_01 2.5/500mg (After)
Sponsors
Dong-A ST Co., Ltd.
Conditions
Healthy
Phase 1
Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State
NCT05739877
Start: 2023-03-17End: 2023-04-07Target: 34Updated: 2023-02-22
Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State
NCT05739851
Start: 2023-03-18End: 2023-04-14Target: 40Updated: 2023-02-22